The OnSight 3D Extremity System captures weight-bearing 3D extremity exams. Now, our advanced CMAR 2 Software takes metal-reduction capabilities to a new level. It reduces the visual distortion caused by screws, implants and other metal, for improved visibility and exceptional diagnostic confidence. 

Download the white paper.

Siris Medical Inc. announced the release of its new artificial intelligence (AI) treatment decision-support system for use in radiation oncology. The new PlanMD software enables radiation oncology clinical teams to leverage patient data and artificial intelligence to efficiently empower their treatment decisions. The software is the first and only tool, according to the company, that enables the physician to see the effect of editing contours in real time, without re-optimizing or replanning.

Fujifilm Medical Systems U.S.A. Inc. recently introduced the FCT Embrace computed tomography (CT) system. Powered by Analogic, the FCT Embrace is the world’s first 85cm wide bore CT imaging unit with 64- or 128-slice configurations, according to the company. Optimized for both oncology and radiology applications, the FCT Embrace, combined with other oncology solutions, offers enhanced and efficient CT simulation with radiotherapy treatment planning capabilities. The unveiling during the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Texas, marks Fujifilm’s entry into the CT market.

Varian announced its new single-room proton therapy system, ProBeam 360°, at the 2018 American Society of Radiation Oncology (ASTRO) annual meeting, Oct. 21-24 in San Antonio, Texas. With a 30 percent smaller footprint than the previous system, ProBeam 360° offers uncompromised clinical capabilities, according to Varian, while reducing vault construction costs by approximately 25 percent. The new system has a 360-degree rotating gantry, a powerful particle accelerator, iterative cone-beam computed tomography (CBCT) imaging and high-definition pencil-beam scanning technology. The system can also provide clinicians a viable path to potential next-generation treatments such as Flash therapy.

Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease risk assessment, according to a new study appearing in the journal Radiology.

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018
ITN Contributing Editor Greg Freiherr interviews researchers about SBRT results.

With its shorter course of treatment, stereotactic body radiation therapy (SBRT) has long been preferred for patients with prostate cancer, particularly given that this form of cancer has appeared to be more sensitive to higher doses per treatments. Concern has lingered, however, about its safety. Those concerns have been put to rest for low and intermediate-risk prostate cancer, according to a researcher from the University of California, Los Angeles.

Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus, according to a randomized phase III NRG Oncology trial. Trial results were presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Texas.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now